High-dose once-weekly rosuvastatin shows comparable safety/efficacy to standard daily atorvastatin April 12, 2011
New PET tracer BAY-94-9392 distinguishes tumors from inflammation in vivo; phase I trials ongoing April 12, 2011
Danoprevir/ritonavir shows anti-HCV efficacy in combination with P/R in P/R null reponders April 11, 2011
RSS